Concepedia

Catherine Lanagan

CL

Statistics

Publications

7

Citations

601

H-Index

7

Active since

2003

Affiliations

QIMR Berghofer Medical Research Institute(Current)

Queensland University of Technology

Mater Adult Hospital

The University of Queensland

Mater Research

Catherine Lanagan is an author at QIMR Berghofer Medical Research Institute specializing in oncology, life sciences, and molecular oncology.

Publications per year

2003–2019

7

Publications

7

Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencing

Mitchell Stark, Susan L. Woods, Michael G. Gartside et al. · Nature Genetics · 2011 · 195 citations

Medicine, Genetics, Oncology +16

Durable complete clinical responses in a phase I/II trial using an autologous melanoma cell/dendritic cell vaccine

Michael G. E. OʼRourke, Maree K. Johnson, Catherine Lanagan et al. · Cancer Immunology Immunotherapy · 2003 · 186 citations · Full text

Medicine, Immunology, Oncology +16

miR-514a regulates the tumour suppressor NF1 and modulates BRAFi sensitivity in melanoma

Mitchell Stark, Vanessa Bonazzi, Glen M. Boyle et al. · Oncotarget · 2015 · 96 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Dendritic cell immunotherapy for stage IV melanoma

Michael G. E. OʼRourke, Maree K. Johnson, Catherine Lanagan et al. · Melanoma Research · 2007 · 51 citations

Medicine, Immunology, Oncology +17

Endogenous Replication Stress Marks Melanomas Sensitive to CHEK1 Inhibitors <i>In Vivo</i>

Zay Yar Oo, Alexander J. Stevenson, Martina Proctor et al. · Clinical Cancer Research · 2018 · 28 citations

Life Sciences, Molecular Biology, Oncology +17

1–5 of 7